Proxalutamide
- Generic Name
- Proxalutamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H19F4N5O2S
- CAS Number
- 1398046-21-3
- Unique Ingredient Identifier
- QX6O64GP40
- Background
Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).
- Indication
用于转移性去势抵抗性前列腺癌（mCRPC）和转移性乳腺癌患者的治疗。
- Associated Conditions
- -
- Associated Therapies
- -
The South Proxa-Rescue AndroCoV Trial Against COVID-19
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Corpometria Institute
- Target Recruit Count
- 133
- Registration Number
- NCT05126628
- Locations
- 🇧🇷
Corpometria Institute, Brasília, DF, Brazil
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Hongqian Guo
- Target Recruit Count
- 2
- Registration Number
- NCT05076851
- Locations
- 🇨🇳
The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
- Conditions
- Interventions
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Applied Biology, Inc.
- Registration Number
- NCT04853927
- Locations
- 🇧🇷
Samel Hospital, Manaus, Amazonas, Brazil
Proxalutamide Treatment for COVID-19 Female Outpatients
- Conditions
- Interventions
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Applied Biology, Inc.
- Registration Number
- NCT04853134
- Locations
- 🇧🇷
Corpometria Institute, Brasilia, Brazil
Proxalutamide Treatment for Hospitalized COVID-19 Patients
- Conditions
- Interventions
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2021-06-24
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 645
- Registration Number
- NCT04728802
- Locations
- 🇧🇷
Hospital Oscar Nicolau, Manaus, Amazonas, Brazil
🇧🇷Hospital Raimunda Francisca Dinelli da Silva, Maues, Amazonas, Brazil
🇧🇷Hospital Regional José Mendes, Itacoatiara, Amazonas, Brazil
Anti-Androgen Treatment for COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 268
- Registration Number
- NCT04446429
- Locations
- 🇧🇷
Corpometria Institute, Brasilia, Brazil
Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Target Recruit Count
- 63
- Registration Number
- NCT04103853
- Locations
- 🇨🇳
Sun-Yat-sen University Cancer center, Guangzhou, Fujian, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.